Dang Chi V, O'donnell Kathryn A, Juopperi Tarja
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Cancer Cell. 2005 Sep;8(3):177-8. doi: 10.1016/j.ccr.2005.08.005.
Increased wild-type MYC expression occurs frequently in human cancers, except in Burkitt's lymphoma, where the translocated MYC allele is frequently mutated at several hotspots, including a major one at threonine-58. Acute MYC expression increases p53 or ARF levels and induces apoptosis, and previous transgenic animal studies revealed frequent inactivating mutations of p53 or p19ARF in transgenic Myc-induced lymphomas. Lowe and coworkers (Hemann et al., 2005) demonstrate that wild-type MYC can also trigger apoptosis by inducing Bim, which neutralizes Bcl-2. In contrast, the MYC point mutants failed to induce Bim, promoting murine lymphomas that escaped both wild-type p53 and p19ARF, and in doing so, evaded apoptosis.
除了伯基特淋巴瘤外,野生型MYC表达增加在人类癌症中很常见,在伯基特淋巴瘤中,易位的MYC等位基因在几个热点区域经常发生突变,包括苏氨酸-58处的一个主要热点。急性MYC表达会增加p53或ARF水平并诱导细胞凋亡,先前的转基因动物研究表明,在转基因Myc诱导的淋巴瘤中p53或p19ARF经常发生失活突变。Lowe及其同事(Hemann等人,2005年)证明,野生型MYC也可以通过诱导Bim触发细胞凋亡,Bim可中和Bcl-2。相反,MYC点突变体未能诱导Bim,从而促进了逃避野生型p53和p19ARF的小鼠淋巴瘤,进而逃避了细胞凋亡。